Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MRNS advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .
a developer of innovative neuropsychiatric therapeutics
Industry Biotechnology